An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed or Refractory

  • Hayslip, John (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date2/9/127/31/15